![Robert Gundel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Robert Gundel is the founder of Chatham Consulting Group, Inc. (founded in 2007).
He was the President, CEO & Non-Independent Director of ProMIS Neurosciences, Inc. from 2010 to 2015.
He held the position of Director-Pharmacology at Bayer Corp.
and Vice President-Pharmacology & Preclinical Research at Chiron Corp.
He was also the Chief Scientific Officer at Arius Research, Inc. in 2008 and Vice President-Research & Development at Elusys Therapeutics, Inc. in 2008.
In addition, he served as the Interim Chief Scientific & Technology Officer at Scorpius Holdings, Inc. in 2009 and Vice President-Scientific & Corporate Development at XOMA (US) LLC from 2005 to 2007.
Dr. Gundel holds an MBA from St. Mary's College of California and a doctorate from New York Medical College.
Anciens postes connus de Robert Gundel
| Sociétés | Poste | Fin |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Directeur Général | 29/06/2015 |
| SCORPIUS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2009 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Directeur Technique/Scientifique/R&D | 01/11/2008 |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Directeur Technique/Scientifique/R&D | 01/01/2008 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Corporate Officer/Principal | 01/01/2007 |
Formation de Robert Gundel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Arius Research, Inc.
Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-stimulatory and immune-derived therapies for the treatment of infectious diseases | Health Technology |
Scorpius Holdings, Inc.
 Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
St. Mary's College of California
 St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York Medical College
 New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
Chatham Consulting Group, Inc.
 Chatham Consulting Group, Inc. Insurance Brokers/ServicesFinance Chatham Consulting Group, Inc. is a private company based in Armonk, NY. The company was founded by Robert Gundel. | Finance |
